openPR Logo
Press release

Paediatric Spasticity Treatment Market Future Demands, Regional Developments and Industry Competitive Landscape Analysis

08-31-2022 03:07 PM CET | Health & Medicine

Press release from: Future Market Insights

Paediatric Spasticity Treatment Market

Paediatric Spasticity Treatment Market

The paediatric spasticity treatment market is expected to register a CAGR of 10% during the forecast period. Paediatric Spasticity results due to damage of portion of brain or spinal cord which controls the voluntary movement. When paediatric spasticity occurs due to injury or disease, nerve signals do not reach muscles and continuously contract which causes stiffness and tightness which interfere with movement and speech.
Several drugs are available to treat the Paediatric Spasticity, drugs are injected into the affected nerve or the muscle. Physical therapy used to increase strength, improve muscle mobility and muscle coordination, use of braces, and electrical stimulation.

Oral medication for treatment of paediatric spasticity is considered when spasticity symptoms gets adverse and start affecting daily muscle functioning. According to estimates from CDC's Autism and Developmental Disabilities Monitoring (ADDM) Network, about 1 in 323 children has been identified with Cerebral Palsy and most (77.4%) of the children identified with CP had spastic CP.

Paediatric Spasticity Treatment: Market Dynamics

Increasing awareness, growing research and development for drug development drive the market of paediatric spasticity treatment in the near future. Changing lifestyle, developing new and innovative technology, improving healthcare infrastructure is expected to fuel the paediatric spasticity treatment market in the forecast period.
Launch of novel therapeutics and growing per capita income in the emerging economies such as China, Brazil is further drive the paediatric spasticity treatment market.
Despite many factors which drive the global market for paediatric spasticity treatment, various factor which might hinder the growth of paediatric spasticity treatment market include high cost of treatment and low awareness in under developed and developing countries and rigorous regulations for the approval of drug.

Paediatric Spasticity Treatment: Overview

Advancement and development of new therapeutic treatment and growing clinical trials for the paediatric spasticity treatment creates huge opportunity for the paediatric spasticity treatment market to grow in the forecast period. Collaboration and partnership among major players for developing new drugs, increasing funding for the research will drive the market of paediatric spasticity treatment in near future. For instance, in august 2016, FDA Approved Ipsen's Dysport (abobotulinumtoxina) injection for the treatment of lower limb spasticity in children aged two and older.

Request Sample Report:
https://www.futuremarketinsights.com/reports/sample/rep-gb-9408

Paediatric Spasticity Treatment: Region-wise Outlook

The North America is expected to contribute to a major share in the global paediatric spasticity treatment, owing to increasing population, increasing number of screening procedures, presence of major manufacturers and growing clinical trials.

Well-developed healthcare facilities and government funding for drug development further drive the market for paediatric spasticity treatment. Europe contributes for the second largest share with significant growth in the global paediatric spasticity treatment market owing to technological advancement in the treatment coupled with growing adoption of new treatment. Asia Pacific market is primarily driven by the factors such as growing prevalence, increasing population, growing awareness of new treatment options.

China is expected to register rapid growth in the paediatric spasticity treatment market, due to large patient pool, availability of new drugs for the paediatric spasticity treatment. Latin America and Middle East & Africa are projected to show sluggish growth in paediatric spasticity treatment market, due to less awareness, lack of adequate healthcare facilities and less developed infrastructure.
Pediatric Spasticity Treatment: Key Players
Some of the key players present in the global pediatric spasticity treatment market are Allergan plc, Ipsen Biopharmaceuticals, Inc., Almirall, S.A, Piramal Critical Care, Inc., Genentech, Inc, Sanofi, Saol Therapeutics, US WorldMeds, LLC among others.

Ask for Customization:
https://www.futuremarketinsights.com/customization-available/rep-gb-9408

Table of Content

1. Executive Summary
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations

2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations

3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Product Life Cycle Analysis
3.5. Investment Feasibility Matrix
3.6. PESTLE and Porter's Analysis
3.7. Regulatory Landscape
3.7.1. By Key Regions
3.7.2. By Key Countries
3.8. Regional Parent Market Outlook

4. Global Paediatric Spasticity Treatment Market Analysis 2017-2021 and Forecast, 2022-2032
4.1. Historical Market Size Value (US$ Mn) Analysis, 2017-2021
4.2. Current and Future Market Size Value (US$ Mn) Projections, 2022-2032
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis

Inquire Before Buying This Research Report:
https://www.futuremarketinsights.com/ask-question/rep-gb-9408

Contact:
Future Market Insights, Inc.   
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware - 19713, USA   
T: +1-845-579-5705   
Enquiries: sales@futuremarketinsights.com    
LinkedIn| Twitter| Blogs 

ABOUT FUTURE MARKET INSIGHTS, INC.
Future Market Insights, Inc. is an ESOMAR-certified business consulting & market research firm, a member of the Greater New York Chamber of Commerce and is headquartered in Delaware, USA. A recipient of Clutch Leaders Award 2022 on account of high client score (4.9/5), we have been collaborating with global enterprises in their business transformation journey and helping them deliver on their business ambitions. 80% of the largest Forbes 1000 enterprises are our clients. We serve global clients across all leading & niche market segments across all major industries.
Now avail flexible Research Subscriptions, and access Research multi-format through downloadable databooks, infographics, charts, interactive playbook for data visualization and full reports through MarketNgage, the market intelligence engine from Future Market Insights. Sign Up for a 7 day free trial!

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Paediatric Spasticity Treatment Market Future Demands, Regional Developments and Industry Competitive Landscape Analysis here

News-ID: 2721125 • Views:

More Releases from Future Market Insights

External Anti-infective Preparations Market USD 6,728.7 Million through 2035, Driven by Innovation and Expanding Healthcare Access
External Anti-infective Preparations Market USD 6,728.7 Million through 2035, Dr …
The global external anti-infective preparations market is on track for sustained growth, with revenues projected to rise from USD 5,412.8 million in 2025 to approximately USD 6,728.7 million by 2035, representing an absolute increase of USD 1,315.9 million and a compound annual growth rate (CAGR) of 2.2%. This expansion is fueled by the increasing prevalence of external infections and the growing demand for localized antimicrobial treatment solutions across hospitals, clinics,
External Anti-infective Preparations Market USD 6,728.7 Million through 2035, Driven by Innovation and Expanding Healthcare Access
External Anti-infective Preparations Market USD 6,728.7 Million through 2035, Dr …
The global external anti-infective preparations market is on track for sustained growth, with revenues projected to rise from USD 5,412.8 million in 2025 to approximately USD 6,728.7 million by 2035, representing an absolute increase of USD 1,315.9 million and a compound annual growth rate (CAGR) of 2.2%. This expansion is fueled by the increasing prevalence of external infections and the growing demand for localized antimicrobial treatment solutions across hospitals, clinics,
External Anti-infective Preparations Market USD 6,728.7 Million through 2035, Driven by Innovation and Expanding Healthcare Access
External Anti-infective Preparations Market USD 6,728.7 Million through 2035, Dr …
The global external anti-infective preparations market is on track for sustained growth, with revenues projected to rise from USD 5,412.8 million in 2025 to approximately USD 6,728.7 million by 2035, representing an absolute increase of USD 1,315.9 million and a compound annual growth rate (CAGR) of 2.2%. This expansion is fueled by the increasing prevalence of external infections and the growing demand for localized antimicrobial treatment solutions across hospitals, clinics,
External Anti-infective Preparations Market USD 6,728.7 Million through 2035, Driven by Innovation and Expanding Healthcare Access
External Anti-infective Preparations Market USD 6,728.7 Million through 2035, Dr …
The global external anti-infective preparations market is on track for sustained growth, with revenues projected to rise from USD 5,412.8 million in 2025 to approximately USD 6,728.7 million by 2035, representing an absolute increase of USD 1,315.9 million and a compound annual growth rate (CAGR) of 2.2%. This expansion is fueled by the increasing prevalence of external infections and the growing demand for localized antimicrobial treatment solutions across hospitals, clinics,

All 5 Releases


More Releases for Spasticity

Spasticity Market 2025-2034 Business Outlook, Critical Insight and Growth
Introduction Spasticity is a motor disorder characterized by involuntary muscle stiffness, spasms, and exaggerated reflexes caused by damage to the central nervous system (CNS). It frequently occurs as a complication of stroke, multiple sclerosis (MS), cerebral palsy, traumatic brain or spinal cord injury, and other neurological conditions. Spasticity can severely impact mobility, daily functioning, and quality of life, making it a significant healthcare burden worldwide. Treatment approaches combine pharmacological agents, intrathecal therapies,
Muscle Spasticity Market Emerging Trends and Growth Prospects 2034
Introduction Muscle spasticity is a condition characterized by involuntary muscle stiffness, spasms, and increased tone, often resulting from neurological disorders such as multiple sclerosis, cerebral palsy, stroke, or traumatic brain and spinal cord injuries. It significantly impacts mobility and quality of life, making effective management essential. With the rising incidence of neurological diseases and advancements in physiotherapy, drug therapies, and medical devices, the global muscle spasticity market is witnessing steady expansion. According
Spasticity Drugs Market Segments, Growth and Trends by Forecast by 2031
The report is segmented By Drug Type (Baclofen, Botulinum Toxin, Diazepam, Tizanidine, Dantrolene Sodium, and Others), Route of Administration (Oral, Intramuscular, and Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies). The global analysis is further broken-down at regional level and major countries. The Report Offers the Value in USD for the above analysis and segments. Get Sample Copy -https://www.theinsightpartners.com/sample/TIPRE00040811/?utm_source=OpenPR&utm_medium=10831 Major Companies operating in the Spasticity Drugs Market are: Ipsen Pharma Allergan Acorda Therapeutics,
Spasticity Drugs Top Companies Regional and Data Analysis to 2031
The Spasticity Drugs Market market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. Download PDF Brochure at: https://www.theinsightpartners.com/sample/TIPRE00040811/?utm_source=OpenPR&utm_medium=10129 Major Companies operating in the Spasticity Drugs Market are: • Ipsen Pharma • Allergan • Acorda Therapeutics, Inc. • Merz Pharma • Teva Pharmaceutical Industries Ltd. • Novartis AG • Sun Pharmaceutical Industries Ltd. • Beximco Pharmaceuticals Ltd. • Johnson & Johnson Private Limited • Zydus Cadila Contact Us: If you have any queries about this report or if
Spasticity Treatment Market Expecting Huge Demand in Upcoming Years
The Global Spasticity Treatment Market size is estimated at $5.7 Billion in 2025 and is forecast to register an annual growth rate (CAGR) of 4.9% to reach $8.8 Billion by 2034. Download now The latest study released on the Global Spasticity Treatment Market by USD Analytics Market evaluates market size, trend, and forecast to 2034. The Spasticity Treatment market study covers significant research data and proofs to be a handy resource
Muscle Spasticity Market Growth, Research Report, Analysis & Trends 2023-2033
Muscle Spasticity Market Report Overview:       Report Attribute Details Base Year 2022 Forecast Years